Nguyen Sandy T, Benson John C, Bathla Girish, Farnsworth Paul J, Carlson Matthew L, Link Michael J, Lane John I
From the Department of Radiology (S.T.N., J.C.B., G.B., P.J.F., J.I.L.), Mayo Clinic, Rochester, Minnesota.
From the Department of Radiology (S.T.N., J.C.B., G.B., P.J.F., J.I.L.), Mayo Clinic, Rochester, Minnesota
AJNR Am J Neuroradiol. 2025 Jul 1;46(7):1453-1457. doi: 10.3174/ajnr.A8657.
Prior investigations have noted the presence of peritumoral hyperintense signal (a "halo") around vestibular schwannomas on postcontrast 3D T2 FLAIR images. This study evaluated this phenomenon in a cohort of patients undergoing stereotactic radiosurgery.
A retrospective review was completed of consecutive patients with presumed vestibular schwannomas undergoing stereotactic radiosurgery. Tumor size, location, presence or absence of a peritumoral halo, and halo thickness were recorded. Images were reviewed for presence and size of peritumoral hyperintense signal on postcontrast 3D T2 FLAIR images before and after treatment.
Twenty-six patients were included in this study, 14 of whom were women (54.0%). Average age was 62 ± 12 years. Before treatment, a postcontrast 3D T2 FLAIR hyperintense peritumoral halo was seen in 85% of patients, averaging 0.8 ± 0.4 mm in thickness. There was a higher incidence of peritumoral halo in posttreatment patients (96%) than pretreatment patients (85%) ( = .017) with a mean follow-up period of 1.2 years (SD 0.35) from November 12, 2019, to September 5, 2023. The average halo thickness was also larger in posttreatment patients (average =1.4 ± 0.4 mm) compared with pretreatment patients (0.8 ± 0.4 mm) ( < .001). Average tumoral size did not significantly change following treatment ( = .10).
Vestibular schwannomas treated with stereotactic radiosurgery are more likely to have a peritumoral halo on postcontrast 3D T2 FLAIR images, with larger halo size as compared with pretreatment studies. Further study with a larger tumor cohort and longer follow-up will be necessary to determine if these findings are predictive of subsequent tumor shrinkage.
先前的研究已注意到,在增强后的三维T2液体衰减反转恢复(FLAIR)图像上,前庭神经鞘瘤周围存在瘤周高信号(“晕”)。本研究在一组接受立体定向放射外科治疗的患者中评估了这一现象。
对连续接受立体定向放射外科治疗的疑似前庭神经鞘瘤患者进行回顾性研究。记录肿瘤大小、位置、瘤周晕的有无及晕的厚度。在治疗前后的增强三维T2 FLAIR图像上,观察瘤周高信号的有无及大小。
本研究纳入26例患者,其中14例为女性(54.0%)。平均年龄为62±12岁。治疗前,85%的患者在增强三维T2 FLAIR图像上可见瘤周高信号晕,平均厚度为0.8±0.4mm。从2019年11月12日至2023年9月5日,平均随访1.2年(标准差0.35),治疗后患者瘤周晕的发生率(96%)高于治疗前患者(85%)(P = 0.017)。与治疗前患者(0.8±0.4mm)相比,治疗后患者的平均晕厚度也更大(平均 = 1.4±0.4mm)(P < 0.001)。治疗后肿瘤平均大小无显著变化(P = 0.10)。
接受立体定向放射外科治疗的前庭神经鞘瘤在增强三维T2 FLAIR图像上更易出现瘤周晕,与治疗前研究相比,晕的大小更大。需要对更大的肿瘤队列进行进一步研究并延长随访时间,以确定这些发现是否可预测后续肿瘤缩小。